Effects of Continuous Medicaid Coverage in 2020–2023 on Children's Health Insurance Coverage, Access to Care, Health Services Use by Type, and Health Status
Health Services Research · 2026
DOI: 10.1111/1475-6773.70034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Services Research, 2026. Verfasst von Wei Lyu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Services Administration, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Medicaid, Health Services Accessibility, Insurance Coverage, Health Status. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
To examine the effects of continuous Medicaid coverage in 2020–2023 under the Families First Coronavirus Response Act (FFCRA) on children's health insurance coverage, access to care, likelihood of using healthcare services by type, and health status. Study Setting and Design A difference‐in‐differences event study compares outcomes pre and post FFCRA between states without pre‐FFCRA continuity provisions (treatment group) and those that required 12‐month continuous coverage (control group). Data Sources and Analytical Sample The main sample includes 122,901–126,117 children (depending on outcome) aged 1–17 years with family income below 300% of federal poverty level from the 2016–2023 National Survey of Children's Health. Primary Findings After FFCRA, public coverage increased in treatment states in 2020, 2021, and 2022 by 4.1 (95% CI: 0.004, 8.3), 4.7 (95% CI, 0.4, 9.0), and 5.4 (95% CI: 2.0, 8.7) percentage points, respectively, relative to control states. Privately purchased coverage declined in 2020 by 3.5 (95% CI: −5.3, −1.7) percentage points. The likelihood of having a usual place for sick care increased by 3.6 (95% CI: 0.5, 6.8) percentage points in 2021, and the likelihood of unmet care needs decreased by 1.7 (95% CI: −2.8, −0.7) and 2.4 (95% CI: −3.8, −1.0) percentage points in 2021 and 2022. The likelihood of excellent/very good health increased by 2.5 (95% CI: 0.4, 4.5), 3.8 (95% CI: 0.7, 6.8), and 2.7 (95% CI: 0.4, 5.0) percentage points in 2020, 2021, and 2023, respectively. There were no changes in the likelihood of medical, preventive, mental health, specialist, and emergency department visits and hospital admissions.
Conclusions
Medicaid continuity under the FFCRA increased the children's public coverage rate. Despite potential switching from private coverage, there is evidence for reductions in unmet care needs and improved health status. Findings provide insights into potential effects of recent federal requirements that all states provide 12‐month Medicaid continuity for children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Services Administration, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Health Management and Policy, University of Iowa, Iowa City, Iowa, USA.
- Department of Economics, University of Iowa, Iowa City, Iowa, USA.
- National Bureau of Economic Research, Cambridge, Massachusetts, USA.
ORCID-Profile: George L Wehby
Zitieren
APA
Lyu, W., & Wehby, G. L. (2026). Effects of Continuous Medicaid Coverage in 2020–2023 on Children's Health Insurance Coverage, Access to Care, Health Services Use by Type, and Health Status. Health Services Research. https://doi.org/10.1111/1475-6773.70034
Vancouver
Lyu W, Wehby GL. Effects of Continuous Medicaid Coverage in 2020–2023 on Children's Health Insurance Coverage, Access to Care, Health Services Use by Type, and Health Status. Health Services Research. 2026. doi:10.1111/1475-6773.70034
BibTeX
@article{Lyu2026,
author = {Lyu, Wei and Wehby, George L},
title = {Effects of Continuous Medicaid Coverage in 2020–2023 on Children's Health Insurance Coverage, Access to Care, Health Services Use by Type, and Health Status},
journal = {Health Services Research},
year = {2026},
doi = {10.1111/1475-6773.70034}
}
EUVIMED